4.6 Article

Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

delta-Secretase-cleaved Tau stimulates A beta production via upregulating STAT1-BACE1 signaling in Alzheimer's disease

Zhentao Zhang et al.

Summary: This study reveals that the fragments generated by delta-secretase cleavage, APP and Tau, act additively to drive AD pathogenesis and cognitive dysfunctions. Tau(1-368) fragment enhances BACE1 expression and A beta generation, and has a more robust effect than full-length Tau, promoting the nuclear translocation of active STAT1 and increasing BACE1 and A beta production. Further mechanism involving A beta-activated kinases phosphorylating STAT1 and its association with Tau(1-368) is also discussed.

MOLECULAR PSYCHIATRY (2021)

Editorial Material Neurosciences

Early Intervention in Alzheimer's Disease: How Early is Early Enough?

Dong-Yu Fan et al.

NEUROSCIENCE BULLETIN (2020)

Review Neurosciences

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Zhentao Zhang et al.

TRANSLATIONAL NEURODEGENERATION (2020)

Review Biochemistry & Molecular Biology

Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease

Seong Su Kang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Multidisciplinary Sciences

Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies

Jie Xiang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

Editorial Material Medicine, General & Internal

Why do so many clinical trials of therapies for Alzheimer's disease fail?

Roy M. Anderson et al.

LANCET (2017)

Article Multidisciplinary Sciences

Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease

Zhentao Zhang et al.

NATURE COMMUNICATIONS (2017)

Article Clinical Neurology

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

Bruno Dubois et al.

ALZHEIMERS & DEMENTIA (2016)

Review Pharmacology & Pharmacy

Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases

Zhentao Zhang et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2016)

Article Immunology

Microglial immunophenotype in dementia with Alzheimer's pathology

Thais Minett et al.

JOURNAL OF NEUROINFLAMMATION (2016)

Article Neurosciences

Clinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai

Chun-Xia Ban et al.

TRANSLATIONAL NEURODEGENERATION (2016)

Article Multidisciplinary Sciences

Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease

Zhentao Zhang et al.

NATURE COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease

Zhentao Zhang et al.

NATURE MEDICINE (2014)

Article Pharmacology & Pharmacy

The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease

John E. Morley et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Review Neurosciences

Prevention strategies for Alzheimer's disease

Serge Gauthier et al.

TRANSLATIONAL NEURODEGENERATION (2012)

Review Pharmacology & Pharmacy

Animal models in the drug discovery pipeline for Alzheimer's disease

Debby Van Dam et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Review Biochemistry & Molecular Biology

The Senescence-accelerated Mouse (SAM): A Higher Oxidative Stress and Age-dependent Degenerative Diseases Model

Yoichi Chiba et al.

NEUROCHEMICAL RESEARCH (2009)